METOROPROLOL TARTRATE

METOROPROLOL TARTRATE was reported 66567 times

METOROPROLOL TARTRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRASH SYNDROME 139 0.0990
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 79 0.0744
2 BODY TINEA 41 0.0732
3 NEPHROGENIC ANAEMIA 290 0.0625
4 HYPERPARATHYROIDISM SECONDARY 155 0.0618
5 HYPERTENSIVE EMERGENCY 68 0.0577
6 ESSENTIAL HYPERTENSION 78 0.0426
7 REBOUND ACID HYPERSECRETION 111 0.0367
8 NEPHROGENIC SYSTEMIC FIBROSIS 110 0.0364
9 LEFT ATRIAL DILATATION 43 0.0337
10 ECHOCARDIOGRAM ABNORMAL 46 0.0329
11 LOSS OF EMPLOYMENT 94 0.0311
12 OBSTRUCTIVE SLEEP APNOEA SYNDROME 44 0.0302
13 END STAGE RENAL DISEASE 535 0.0293
14 FIBROSIS 81 0.0263
15 SKIN INDURATION 54 0.0260
16 INHIBITORY DRUG INTERACTION 41 0.0259
17 SKIN HYPERTROPHY 67 0.0238
18 OCCULT BLOOD POSITIVE 46 0.0234
19 ATRIAL FLUTTER 186 0.0233
20 ATRIOVENTRICULAR BLOCK FIRST DEGREE 100 0.0230
21 LEFT VENTRICULAR HYPERTROPHY 95 0.0222
22 ORTHOPNOEA 68 0.0213
23 AORTIC STENOSIS 71 0.0204
24 HAEMORRHAGIC ANAEMIA 87 0.0198
25 BLOOD CHLORIDE DECREASED 51 0.0198
26 RENAL FAILURE CHRONIC 149 0.0194
27 ATRIAL FIBRILLATION 1878 0.0193
28 CORONARY ARTERY STENOSIS 96 0.0191
29 ANGINA UNSTABLE 122 0.0188
30 INFECTION SUSCEPTIBILITY INCREASED 40 0.0183
31 HYPERLIPIDAEMIA 216 0.0181
32 VENTRICULAR HYPOKINESIA 58 0.0180
33 BLOOD PRESSURE INADEQUATELY CONTROLLED 108 0.0179
34 ARTERIOSCLEROSIS CORONARY ARTERY 117 0.0176
35 RENAL INJURY 521 0.0175
36 SINUS BRADYCARDIA 169 0.0175
37 CORONARY ARTERY OCCLUSION 239 0.0174
38 BLOOD PRESSURE SYSTOLIC DECREASED 79 0.0174
39 AORTIC ARTERIOSCLEROSIS 44 0.0171
40 MITRAL VALVE INCOMPETENCE 191 0.0169
41 BLOOD PHOSPHORUS INCREASED 46 0.0168
42 TACHYARRHYTHMIA 42 0.0168
43 BRADYCARDIA 891 0.0168
44 CHRONIC KIDNEY DISEASE 1272 0.0167
45 LEFT VENTRICULAR FAILURE 56 0.0163
46 CARDIAC FAILURE CHRONIC 69 0.0162
47 NEPHROPATHY 151 0.0162
48 CORONARY ARTERY DISEASE 486 0.0160
49 CAROTID ARTERY STENOSIS 56 0.0160
50 HYPOVOLAEMIA 93 0.0159
51 HEART VALVE INCOMPETENCE 45 0.0157
52 LOWER GASTROINTESTINAL HAEMORRHAGE 116 0.0157
53 BODY HEIGHT DECREASED 167 0.0156
54 THERAPEUTIC AGENT TOXICITY 52 0.0156
55 PERIPHERAL VASCULAR DISORDER 80 0.0155
56 INTRACARDIAC THROMBUS 47 0.0153
57 CARDIAC FAILURE CONGESTIVE 1222 0.0152
58 DYSLIPIDAEMIA 77 0.0151
59 GLUCOSE TOLERANCE IMPAIRED 89 0.0150
60 SUPRAVENTRICULAR TACHYCARDIA 144 0.0150
61 CARDIOMEGALY 185 0.0150
62 ATRIOVENTRICULAR BLOCK 115 0.0149
63 RHINITIS ALLERGIC 66 0.0148
64 INTERNATIONAL NORMALISED RATIO INCREASED 419 0.0147
65 MULTIPLE INJURIES 92 0.0146
66 TRICUSPID VALVE INCOMPETENCE 116 0.0146
67 NON-CARDIAC CHEST PAIN 46 0.0145
68 VENTRICULAR TACHYCARDIA 240 0.0145
69 HEART RATE ABNORMAL 81 0.0145
70 TROPONIN INCREASED 110 0.0144
71 GOUT 259 0.0144
72 BUNDLE BRANCH BLOCK LEFT 61 0.0144
73 ISCHAEMIC CARDIOMYOPATHY 44 0.0143
74 DIASTOLIC DYSFUNCTION 44 0.0142
75 RENAL CYST 113 0.0142
76 VENTRICULAR ARRHYTHMIA 52 0.0142
77 CARDIOGENIC SHOCK 204 0.0142
78 SUPRAVENTRICULAR EXTRASYSTOLES 48 0.0142
79 DIVERTICULUM INTESTINAL 62 0.0142
80 RENAL FAILURE ACUTE 599 0.0141
81 ATRIOVENTRICULAR BLOCK COMPLETE 94 0.0140
82 ATELECTASIS 135 0.0140
83 ECONOMIC PROBLEM 211 0.0139
84 PURPURA 123 0.0139
85 PROTHROMBIN TIME PROLONGED 83 0.0139
86 CORONARY ARTERIAL STENT INSERTION 70 0.0138
87 PRE-EXISTING CONDITION IMPROVED 86 0.0138
88 HEART RATE IRREGULAR 310 0.0137
89 CARDIAC VALVE DISEASE 78 0.0136
90 CARDIAC MURMUR 118 0.0136
91 AORTIC VALVE INCOMPETENCE 58 0.0136
92 ANGINA PECTORIS 386 0.0135
93 INTERNATIONAL NORMALISED RATIO DECREASED 54 0.0133
94 ARTERIAL OCCLUSIVE DISEASE 104 0.0132
95 DIVERTICULUM 94 0.0132
96 BLOOD ALBUMIN DECREASED 104 0.0131
97 EJECTION FRACTION DECREASED 203 0.0130
98 ACUTE MYOCARDIAL INFARCTION 385 0.0130
99 DIABETIC NEUROPATHY 64 0.0129
100 RENAL FAILURE 1716 0.0129
101 HEART RATE DECREASED 452 0.0129
102 VENTRICULAR EXTRASYSTOLES 133 0.0128
103 HYPERVOLAEMIA 63 0.0127
104 HYPERKALAEMIA 445 0.0127
105 SLEEP APNOEA SYNDROME 242 0.0127
106 BLOOD POTASSIUM INCREASED 205 0.0126
107 HEPATIC STEATOSIS 229 0.0123
108 CORONARY ARTERY BYPASS 70 0.0122
109 HYPERKERATOSIS 67 0.0121
110 LUNG INFILTRATION 107 0.0121
111 MULTIPLE MYELOMA 56 0.0120
112 HIGH DENSITY LIPOPROTEIN DECREASED 40 0.0120
113 DIZZINESS POSTURAL 116 0.0120
114 ACUTE CORONARY SYNDROME 99 0.0119
115 BREATH SOUNDS ABNORMAL 58 0.0118
116 VITAMIN D DEFICIENCY 114 0.0117
117 ARTERIOSCLEROSIS 110 0.0117
118 SEASONAL ALLERGY 165 0.0116
119 MYOCARDIAL ISCHAEMIA 132 0.0116
120 HAEMATOCRIT DECREASED 229 0.0115
121 BUNDLE BRANCH BLOCK RIGHT 53 0.0115
122 BLOOD UREA INCREASED 193 0.0115
123 INCREASED TENDENCY TO BRUISE 106 0.0115
124 CANDIDIASIS 46 0.0115
125 HOSPICE CARE 113 0.0114
126 RENAL TUBULAR NECROSIS 112 0.0114
127 BLOOD PRESSURE DIASTOLIC DECREASED 84 0.0114
128 MENTAL STATUS CHANGES 316 0.0114
129 HEPARIN-INDUCED THROMBOCYTOPENIA 56 0.0114
130 EMBOLIC STROKE 40 0.0114
131 HAEMODIALYSIS 95 0.0113
132 DYSPNOEA EXERTIONAL 426 0.0113
133 CEREBRAL ATROPHY 45 0.0113
134 SKIN TIGHTNESS 53 0.0113
135 PROTEIN URINE PRESENT 56 0.0112
136 HIATUS HERNIA 145 0.0112
137 ACUTE RESPIRATORY FAILURE 212 0.0110
138 CARDIAC PACEMAKER INSERTION 65 0.0109
139 LEFT VENTRICULAR DYSFUNCTION 73 0.0109
140 CATHETERISATION CARDIAC 48 0.0108
141 BLOOD SODIUM DECREASED 203 0.0108
142 MULTI-ORGAN FAILURE 186 0.0107
143 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 55 0.0107
144 ORTHOSTATIC HYPOTENSION 186 0.0107
145 RALES 62 0.0107
146 VENTRICULAR FIBRILLATION 117 0.0105
147 BENIGN PROSTATIC HYPERPLASIA 54 0.0104
148 PROSTATOMEGALY 41 0.0104
149 UNRESPONSIVE TO STIMULI 269 0.0104
150 STENT PLACEMENT 84 0.0104
151 BLOOD PRESSURE ABNORMAL 206 0.0104
152 CARDIAC OPERATION 89 0.0103
153 RENAL FUNCTION TEST ABNORMAL 48 0.0103
154 BODY TEMPERATURE DECREASED 101 0.0102
155 OVERWEIGHT 55 0.0102
156 UPPER GASTROINTESTINAL HAEMORRHAGE 172 0.0102
157 KIDNEY TRANSPLANT REJECTION 49 0.0102
158 RED CELL DISTRIBUTION WIDTH INCREASED 42 0.0101
159 BLOOD MAGNESIUM DECREASED 87 0.0101
160 HYPOTENSION 2022 0.0101
161 URINE OUTPUT DECREASED 88 0.0101
162 CARDIAC FLUTTER 65 0.0100
163 EXTRASYSTOLES 70 0.0100
164 WEIGHT FLUCTUATION 104 0.0099
165 ECCHYMOSIS 68 0.0099
166 PULSE ABSENT 47 0.0099
167 CARDIOMYOPATHY 146 0.0099
168 FLUSHING 1004 0.0099
169 ANHEDONIA 259 0.0098
170 FAILURE TO THRIVE 51 0.0098
171 GASTROINTESTINAL HAEMORRHAGE 811 0.0097
172 PULMONARY HYPERTENSION 202 0.0097
173 GLOMERULAR FILTRATION RATE DECREASED 119 0.0097
174 BLOOD POTASSIUM DECREASED 291 0.0097
175 CONGESTIVE CARDIOMYOPATHY 40 0.0096
176 BLOOD PRESSURE SYSTOLIC INCREASED 187 0.0096
177 FULL BLOOD COUNT DECREASED 192 0.0095
178 SPINAL COLUMN STENOSIS 45 0.0095
179 INTERVERTEBRAL DISC DEGENERATION 88 0.0095
180 OEDEMA PERIPHERAL 1157 0.0095
181 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 48 0.0095
182 AORTIC ANEURYSM 72 0.0095
183 SPINAL OSTEOARTHRITIS 83 0.0094
184 TORSADE DE POINTES 74 0.0094
185 BLOOD CALCIUM DECREASED 106 0.0094
186 ISCHAEMIA 43 0.0093
187 CARDIAC FAILURE ACUTE 62 0.0093
188 ELECTROCARDIOGRAM ABNORMAL 73 0.0093
189 DIALYSIS 132 0.0093
190 CLOSTRIDIUM DIFFICILE COLITIS 97 0.0091
191 ACUTE KIDNEY INJURY 1397 0.0091
192 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 476 0.0091
193 COAGULOPATHY 151 0.0091
194 BLOOD URINE PRESENT 172 0.0091
195 HAEMOGLOBIN DECREASED 927 0.0090
196 NOCTURIA 109 0.0090
197 MYOCARDIAL INFARCTION 1561 0.0089
198 ORAL PAIN 200 0.0089
199 PULMONARY OEDEMA 398 0.0089
200 BLOOD CREATININE INCREASED 578 0.0088
201 INTERNAL HAEMORRHAGE 101 0.0088
202 PULMONARY CONGESTION 116 0.0088
203 FEAR 236 0.0088
204 HYPOXIA 308 0.0087
205 HAEMORRHAGIC STROKE 68 0.0087
206 ANEURYSM 43 0.0086
207 ELECTROLYTE IMBALANCE 100 0.0086
208 SYNCOPE 857 0.0086
209 ARRHYTHMIA 405 0.0085
210 HAEMODYNAMIC INSTABILITY 65 0.0085
211 FLUID OVERLOAD 124 0.0085
212 BLOOD PRESSURE INCREASED 1301 0.0085
213 TUBULOINTERSTITIAL NEPHRITIS 159 0.0085
214 RED BLOOD CELL COUNT DECREASED 242 0.0085
215 HEART RATE INCREASED 837 0.0084
216 PLEURAL EFFUSION 513 0.0084
217 JOINT RANGE OF MOTION DECREASED 113 0.0084
218 PRODUCT ADMINISTRATION INTERRUPTED 66 0.0084
219 TRANSIENT ISCHAEMIC ATTACK 283 0.0084
220 GASTROOESOPHAGEAL REFLUX DISEASE 675 0.0084
221 DECUBITUS ULCER 68 0.0083
222 POOR QUALITY SLEEP 179 0.0083
223 HYPERTENSION 1760 0.0083
224 BLOOD PRESSURE DECREASED 552 0.0083
225 LEUKOCYTOSIS 150 0.0083
226 OBESITY 132 0.0083
227 ULCER HAEMORRHAGE 56 0.0083
228 CHEST PAIN 1529 0.0082
229 DEHYDRATION 1097 0.0082
230 COMPRESSION FRACTURE 44 0.0082
231 CELLULITIS 413 0.0082
232 LOCALISED INFECTION 198 0.0082
233 CARDIAC DISORDER 765 0.0082
234 EXERCISE TOLERANCE DECREASED 47 0.0082
235 GASTRIC ULCER HAEMORRHAGE 45 0.0081
236 CATARACT OPERATION 48 0.0081
237 PERICARDIAL EFFUSION 187 0.0081
238 CARPAL TUNNEL SYNDROME 113 0.0081
239 RHABDOMYOLYSIS 335 0.0080
240 BLOOD PRESSURE FLUCTUATION 192 0.0080
241 INTESTINAL ISCHAEMIA 44 0.0080
242 PERIPHERAL COLDNESS 109 0.0079
243 IRON DEFICIENCY ANAEMIA 73 0.0079
244 LIMB INJURY 214 0.0079
245 ANGIOPATHY 44 0.0078
246 REFUSAL OF TREATMENT BY PATIENT 51 0.0078
247 INFUSION SITE SWELLING 49 0.0078
248 MULTIPLE ALLERGIES 61 0.0078
249 PLATELET COUNT ABNORMAL 47 0.0078
250 CONTUSION 748 0.0078
251 RECTAL HAEMORRHAGE 332 0.0077
252 BLOOD COUNT ABNORMAL 117 0.0077
253 PELVIC FRACTURE 60 0.0077
254 CARDIAC FAILURE 618 0.0077
255 FLUID RETENTION 391 0.0077
256 SUBDURAL HAEMATOMA 110 0.0077
257 RENAL DISORDER 358 0.0077
258 DUODENAL ULCER 54 0.0076
259 HEAD INJURY 241 0.0076
260 FAECES DISCOLOURED 165 0.0076
261 HAEMATOMA 197 0.0076
262 PROSTATIC SPECIFIC ANTIGEN INCREASED 104 0.0075
263 HAEMATURIA 258 0.0075
264 SCIATICA 120 0.0075
265 GASTRITIS 198 0.0075
266 DRUG LEVEL INCREASED 124 0.0075
267 HYPOMAGNESAEMIA 104 0.0075
268 FLANK PAIN 70 0.0075
269 COMPLETED SUICIDE 620 0.0074
270 BURSITIS 90 0.0074
271 ASTHENIA 2779 0.0074
272 FULL BLOOD COUNT ABNORMAL 78 0.0074
273 SKIN LACERATION 80 0.0073
274 EMPHYSEMA 74 0.0073
275 IMPAIRED GASTRIC EMPTYING 100 0.0073
276 BLOOD IRON DECREASED 87 0.0073
277 BLOOD TRIGLYCERIDES INCREASED 129 0.0073
278 RESPIRATORY FAILURE 532 0.0073
279 RIB FRACTURE 150 0.0073
280 CARDIAC ARREST 602 0.0073
281 PRESYNCOPE 177 0.0073
282 HIP FRACTURE 234 0.0073
283 BLOOD URIC ACID INCREASED 42 0.0073
284 HOT FLUSH 548 0.0073
285 URINARY TRACT INFECTION 1239 0.0073
286 COLITIS ISCHAEMIC 49 0.0073
287 PULMONARY MASS 108 0.0072
288 FALL 2408 0.0072
289 HYPOKALAEMIA 333 0.0072
290 HALLUCINATION, VISUAL 152 0.0072
291 CHOLELITHIASIS 236 0.0072
292 DRUG TOXICITY 98 0.0072
293 EPISTAXIS 538 0.0072
294 BLOOD CALCIUM INCREASED 63 0.0072
295 GASTRIC ULCER 136 0.0071
296 PULMONARY THROMBOSIS 78 0.0071
297 HAEMOGLOBIN ABNORMAL 46 0.0071
298 OSTEOARTHRITIS 303 0.0071
299 POST PROCEDURAL HAEMORRHAGE 83 0.0071
300 LACERATION 67 0.0071
301 BLOOD TEST ABNORMAL 100 0.0071
302 PALPITATIONS 832 0.0071
303 TYPE 2 DIABETES MELLITUS 239 0.0071
304 TASTE DISORDER 144 0.0071
305 MELAENA 156 0.0071
306 HAEMORRHAGE INTRACRANIAL 105 0.0070
307 ACTIVITIES OF DAILY LIVING IMPAIRED 139 0.0070
308 VITAMIN D DECREASED 60 0.0070
309 BACK DISORDER 114 0.0070
310 SINUS TACHYCARDIA 99 0.0070
311 IMPAIRED QUALITY OF LIFE 100 0.0069
312 MYOPATHY 60 0.0069
313 SKIN ULCER 179 0.0069
314 POST PROCEDURAL COMPLICATION 132 0.0069
315 BLOOD CHOLESTEROL INCREASED 319 0.0068
316 WALKING AID USER 45 0.0068
317 MOUTH HAEMORRHAGE 50 0.0068
318 METABOLIC ACIDOSIS 218 0.0068
319 JOINT EFFUSION 47 0.0068
320 PRODUCTIVE COUGH 325 0.0068
321 ESCHERICHIA INFECTION 56 0.0068
322 ACIDOSIS 52 0.0068
323 OEDEMA 369 0.0068
324 UPPER RESPIRATORY TRACT INFECTION 314 0.0068
325 DYSURIA 250 0.0068
326 RENAL IMPAIRMENT 570 0.0068
327 SCOLIOSIS 42 0.0068
328 HAEMOPTYSIS 189 0.0068
329 HYPERTHYROIDISM 98 0.0068
330 HAEMORRHOIDS 132 0.0068
331 CEREBRAL DISORDER 50 0.0068
332 SMALL INTESTINAL OBSTRUCTION 83 0.0067
333 GINGIVAL BLEEDING 92 0.0067
334 FEELING HOT 413 0.0067
335 DYSPNOEA 3807 0.0067
336 TOOTH ABSCESS 68 0.0067
337 DIABETES MELLITUS 509 0.0067
338 HEARING IMPAIRED 40 0.0067
339 CYSTITIS 212 0.0067
340 FOOT FRACTURE 126 0.0066
341 INFUSION SITE ERYTHEMA 56 0.0066
342 LABORATORY TEST ABNORMAL 196 0.0066
343 APPETITE DISORDER 44 0.0066
344 GENERALISED OEDEMA 82 0.0066
345 RESTLESS LEGS SYNDROME 120 0.0066
346 STOMATITIS 400 0.0066
347 EYE HAEMORRHAGE 88 0.0066
348 FOREIGN BODY SENSATION IN EYES 42 0.0066
349 COLD SWEAT 116 0.0066
350 PLATELET COUNT DECREASED 701 0.0066
351 DYSSTASIA 192 0.0066
352 AGEUSIA 164 0.0066
353 CONSTIPATION 1433 0.0066
354 POLLAKIURIA 274 0.0066
355 NERVE INJURY 73 0.0066
356 EYE INFECTION 74 0.0065
357 SOMNAMBULISM 43 0.0065
358 INJURY 460 0.0065
359 INSURANCE ISSUE 100 0.0065
360 BRONCHITIS 484 0.0065
361 PNEUMONIA 2114 0.0065
362 MUSCULOSKELETAL CHEST PAIN 101 0.0065
363 CATARACT 388 0.0065
364 UROSEPSIS 60 0.0065
365 LARGE INTESTINE POLYP 45 0.0065
366 DIVERTICULITIS 180 0.0065
367 DECREASED ACTIVITY 70 0.0065
368 RESPIRATORY TRACT CONGESTION 103 0.0065
369 SKIN DISORDER 216 0.0065
370 SEPSIS 722 0.0065
371 PYELONEPHRITIS 56 0.0065
372 ANKLE FRACTURE 100 0.0065
373 DRUG INTERACTION 1024 0.0064
374 HYPERGLYCAEMIA 234 0.0064
375 HYPERCHOLESTEROLAEMIA 62 0.0064
376 KIDNEY INFECTION 126 0.0064
377 HEPATOMEGALY 63 0.0064
378 OESOPHAGITIS 70 0.0064
379 OSTEOPENIA 97 0.0064
380 HYPOTHYROIDISM 204 0.0064
381 HYPERTENSIVE CRISIS 71 0.0064
382 HEMIPARESIS 108 0.0064
383 ANAEMIA 1214 0.0064
384 OXYGEN SATURATION DECREASED 357 0.0063
385 MUSCULOSKELETAL PAIN 332 0.0063
386 HYPERCALCAEMIA 78 0.0063
387 STAPHYLOCOCCAL INFECTION 208 0.0063
388 MICTURITION URGENCY 72 0.0063
389 FLATULENCE 357 0.0063
390 DYSPEPSIA 619 0.0063
391 SINUS CONGESTION 85 0.0063
392 INFUSION SITE PAIN 81 0.0063
393 GINGIVAL PAIN 50 0.0063
394 DIABETES MELLITUS INADEQUATE CONTROL 111 0.0063
395 LACTIC ACIDOSIS 203 0.0063
396 ONYCHOCLASIS 43 0.0062
397 HYPERSOMNIA 179 0.0062
398 INCONTINENCE 66 0.0062
399 MUSCULAR WEAKNESS 706 0.0062
400 DIARRHOEA 4007 0.0062
401 DYSPHONIA 362 0.0062
402 DECREASED APPETITE 1433 0.0062
403 MALNUTRITION 69 0.0062
404 THROMBOSIS 496 0.0062
405 WEIGHT DECREASED 1718 0.0061
406 ENCEPHALOPATHY 151 0.0061
407 TOOTH INFECTION 81 0.0061
408 BALANCE DISORDER 531 0.0061
409 FATIGUE 4774 0.0061
410 DIZZINESS 3057 0.0061
411 ARTHRITIS 482 0.0061
412 WHITE BLOOD CELL COUNT INCREASED 235 0.0061
413 DEEP VEIN THROMBOSIS 397 0.0061
414 TRANSFUSION 64 0.0061
415 CIRCULATORY COLLAPSE 104 0.0061
416 BLINDNESS TRANSIENT 45 0.0061
417 CHEST DISCOMFORT 624 0.0061
418 COUGH 1705 0.0061
419 OSTEOPOROSIS 250 0.0061
420 JOINT STIFFNESS 159 0.0061
421 MIDDLE INSOMNIA 113 0.0060
422 RETCHING 129 0.0060
423 BLADDER DISORDER 60 0.0060
424 ILEUS 75 0.0060
425 GASTRIC DISORDER 207 0.0060
426 BLOOD DISORDER 48 0.0060
427 SUBARACHNOID HAEMORRHAGE 61 0.0060
428 CEREBRAL HAEMORRHAGE 214 0.0060
429 ABDOMINAL DISCOMFORT 1000 0.0060
430 BASAL CELL CARCINOMA 93 0.0060
431 ISCHAEMIC STROKE 106 0.0059
432 UNEVALUABLE EVENT 448 0.0059
433 HYPOGLYCAEMIA 287 0.0059
434 CEREBROVASCULAR ACCIDENT 1002 0.0059
435 EXOSTOSIS 54 0.0059
436 RESPIRATORY ARREST 163 0.0059
437 APNOEA 46 0.0059
438 GAIT DISTURBANCE 1130 0.0059
439 SCAR 101 0.0059
440 LETHARGY 339 0.0059
441 EYE PAIN 332 0.0059
442 HYPONATRAEMIA 331 0.0059
443 SINUS DISORDER 116 0.0059
444 RESPIRATORY RATE INCREASED 52 0.0059
445 CONFUSIONAL STATE 939 0.0058
446 PERIPHERAL SWELLING 893 0.0058
447 ERUCTATION 112 0.0058
448 SHOCK 133 0.0058
449 MACULAR DEGENERATION 69 0.0058
450 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 98 0.0058
451 BACK PAIN 1339 0.0058
452 ROTATOR CUFF SYNDROME 74 0.0058
453 PETECHIAE 60 0.0057
454 WHITE BLOOD CELL COUNT DECREASED 623 0.0057
455 BOWEL MOVEMENT IRREGULARITY 44 0.0057
456 OSTEOMYELITIS 104 0.0057
457 TACHYCARDIA 510 0.0057
458 NEUROPATHY PERIPHERAL 546 0.0057
459 POLYURIA 47 0.0057
460 BACTERAEMIA 68 0.0057
461 GLAUCOMA 110 0.0057
462 HYPOPHAGIA 146 0.0057
463 DISORIENTATION 226 0.0057
464 SPUTUM DISCOLOURED 54 0.0057
465 TOOTH DISORDER 126 0.0057
466 PNEUMONIA BACTERIAL 52 0.0057
467 GASTROENTERITIS VIRAL 102 0.0056
468 ORAL DISCOMFORT 78 0.0056
469 DRY THROAT 57 0.0056
470 ADRENAL INSUFFICIENCY 68 0.0056
471 FOOT DEFORMITY 62 0.0056
472 WRIST FRACTURE 67 0.0056
473 CLOSTRIDIUM DIFFICILE INFECTION 122 0.0056
474 PRODUCT DOSE OMISSION IN ERROR 158 0.0056
475 GROIN PAIN 49 0.0056
476 ANURIA 48 0.0056
477 URINARY INCONTINENCE 165 0.0056
478 SPINAL COMPRESSION FRACTURE 46 0.0056
479 HAEMATEMESIS 141 0.0056
480 NEPHROLITHIASIS 255 0.0056
481 HALLUCINATION 418 0.0055
482 ABASIA 137 0.0055
483 BLOOD GLUCOSE DECREASED 266 0.0055
484 EMBOLISM 46 0.0055
485 INTERVERTEBRAL DISC PROTRUSION 121 0.0055
486 DERMATITIS CONTACT 63 0.0055
487 PLATELET COUNT INCREASED 72 0.0055
488 MASS 77 0.0055
489 LOSS OF CONSCIOUSNESS 704 0.0055
490 HYPERAESTHESIA 45 0.0055
491 DEMENTIA 153 0.0055
492 UPPER LIMB FRACTURE 109 0.0055
493 UPPER-AIRWAY COUGH SYNDROME 45 0.0055
494 EATING DISORDER 116 0.0054
495 ANAL INCONTINENCE 49 0.0054
496 DYSARTHRIA 205 0.0054
497 PLASMA CELL MYELOMA 212 0.0054
498 GRAND MAL CONVULSION 50 0.0054
499 HYPERHIDROSIS 697 0.0054
500 INTENTIONAL DRUG MISUSE 113 0.0054
501 MUSCULOSKELETAL DISCOMFORT 93 0.0054
502 CYST 67 0.0054
503 ARTHROPOD BITE 40 0.0054
504 SKIN DISCOLOURATION 248 0.0054
505 PRODUCT DISTRIBUTION ISSUE 50 0.0054
506 GASTRIC HAEMORRHAGE 62 0.0054
507 DELIRIUM 187 0.0054
508 NEUTROPHIL COUNT INCREASED 55 0.0054
509 DRY MOUTH 435 0.0054
510 EAR DISCOMFORT 55 0.0054
511 BLOOD ALKALINE PHOSPHATASE INCREASED 133 0.0054
512 ANOREXIA 69 0.0053
513 FIBROMYALGIA 130 0.0053
514 COVID-19 PNEUMONIA 63 0.0053
515 BONE DISORDER 97 0.0053
516 PAIN IN EXTREMITY 1568 0.0053
517 MUSCLE SPASMS 976 0.0053
518 MUSCLE DISORDER 43 0.0053
519 SCRATCH 56 0.0053
520 SPLENOMEGALY 62 0.0053
521 HEMIPLEGIA 44 0.0053
522 ABDOMINAL PAIN UPPER 1087 0.0053
523 DYSPHAGIA 501 0.0053
524 TENDERNESS 55 0.0053
525 MEMORY IMPAIRMENT 725 0.0053
526 HERNIA 102 0.0053
527 PHARYNGITIS STREPTOCOCCAL 57 0.0053
528 GALLBLADDER DISORDER 94 0.0053
529 NEURALGIA 128 0.0053
530 SCAB 60 0.0053
531 RHINORRHOEA 340 0.0053
532 MYALGIA 894 0.0053
533 ABNORMAL FAECES 43 0.0052
534 BIPOLAR DISORDER 57 0.0052
535 SPINAL OPERATION 64 0.0052
536 CONCUSSION 40 0.0052
537 CARDIO-RESPIRATORY ARREST 216 0.0052
538 INITIAL INSOMNIA 53 0.0052
539 WHEEZING 305 0.0051
540 GASTROENTERITIS 75 0.0051
541 NECK PAIN 287 0.0051
542 SKIN LESION 140 0.0051
543 APHASIA 154 0.0051
544 NIGHT SWEATS 164 0.0051
545 BLOOD CREATINE PHOSPHOKINASE INCREASED 146 0.0051
546 DENTAL CARIES 56 0.0051
547 MOVEMENT DISORDER 162 0.0050
548 ULCER 80 0.0050
549 ASPIRATION 55 0.0050
550 THROAT IRRITATION 225 0.0050
551 ORAL CANDIDIASIS 66 0.0050
552 HAIR TEXTURE ABNORMAL 67 0.0050
553 PARAESTHESIA 788 0.0050
554 PHARYNGEAL OEDEMA 77 0.0050
555 RESPIRATORY DISTRESS 138 0.0050
556 FEELING COLD 139 0.0050
557 PANCREATITIS ACUTE 112 0.0050
558 BLOOD GLUCOSE INCREASED 937 0.0050
559 HEPATIC ENZYME INCREASED 339 0.0050
560 PRODUCT DOSE OMISSION 324 0.0050
561 PANCYTOPENIA 277 0.0050
562 PANCREATITIS 261 0.0049
563 AMNESIA 321 0.0049
564 FACIAL PAIN 44 0.0049
565 BLOOD BILIRUBIN INCREASED 133 0.0049
566 QUALITY OF LIFE DECREASED 66 0.0049
567 SUDDEN DEATH 52 0.0049
568 CHOLECYSTECTOMY 56 0.0049
569 PULMONARY FIBROSIS 94 0.0049
570 SPINAL FRACTURE 98 0.0049
571 VITREOUS FLOATERS 48 0.0049
572 NAUSEA 3859 0.0049
573 SLEEP DISORDER 344 0.0049
574 THYROID DISORDER 75 0.0049
575 SPINAL PAIN 57 0.0049
576 TEMPERATURE INTOLERANCE 50 0.0048
577 WOUND INFECTION 53 0.0048
578 RESPIRATORY TRACT INFECTION 126 0.0048
579 DELUSION 75 0.0048
580 BLINDNESS UNILATERAL 68 0.0048
581 BURNING SENSATION 337 0.0048
582 SLUGGISHNESS 49 0.0048
583 DEPRESSED LEVEL OF CONSCIOUSNESS 190 0.0048
584 PAIN IN JAW 136 0.0048
585 URINARY RETENTION 160 0.0048
586 SINUSITIS 491 0.0048
587 CHOLECYSTITIS 57 0.0048
588 HAEMATOCHEZIA 264 0.0048
589 TACHYPNOEA 65 0.0048
590 LIVER FUNCTION TEST ABNORMAL 139 0.0048
591 PNEUMONIA ASPIRATION 119 0.0048
592 BONE PAIN 279 0.0048
593 HYPOACUSIS 205 0.0048
594 MUSCLE TIGHTNESS 77 0.0047
595 ANXIETY 1352 0.0047
596 BLOOD GLUCOSE FLUCTUATION 52 0.0047
597 DEPRESSION 1077 0.0047
598 PNEUMOTHORAX 75 0.0047
599 BEDRIDDEN 62 0.0047
600 PRURITUS GENERALISED 102 0.0047
601 GLYCOSYLATED HAEMOGLOBIN INCREASED 119 0.0047
602 INSOMNIA 1255 0.0047
603 KNEE ARTHROPLASTY 99 0.0047
604 BACK INJURY 51 0.0047
605 HERPES ZOSTER 269 0.0047
606 JOINT INJURY 100 0.0047
607 POLYNEUROPATHY 56 0.0047
608 HYPOAESTHESIA 700 0.0047
609 HOSPITALISATION 718 0.0047
610 ABNORMAL DREAMS 129 0.0047
611 INFLUENZA 520 0.0047
612 LEUKAEMIA 44 0.0047
613 ORAL HERPES 91 0.0047
614 BODY TEMPERATURE INCREASED 95 0.0047
615 SKIN HAEMORRHAGE 69 0.0047
616 RASH PRURITIC 252 0.0046
617 SKIN CANCER 100 0.0046
618 VERTIGO 283 0.0046
619 TREMOR 768 0.0046
620 TOOTH FRACTURE 51 0.0046
621 HYPOKINESIA 67 0.0046
622 VISION BLURRED 633 0.0046
623 CHROMATURIA 104 0.0046
624 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 221 0.0046
625 LOWER LIMB FRACTURE 88 0.0046
626 MUSCLE ATROPHY 58 0.0046
627 LIVER DISORDER 203 0.0046
628 GASTROINTESTINAL INFECTION 41 0.0046
629 TREATMENT NONCOMPLIANCE 250 0.0046
630 THERAPY CESSATION 234 0.0046
631 ATAXIA 54 0.0045
632 HYPOTHERMIA 46 0.0045
633 WOUND 127 0.0045
634 NERVOUSNESS 237 0.0045
635 EAR PAIN 88 0.0045
636 HEPATIC CIRRHOSIS 85 0.0045
637 COORDINATION ABNORMAL 63 0.0045
638 SWOLLEN TONGUE 141 0.0045
639 HYPOTONIA 45 0.0045
640 TINNITUS 207 0.0045
641 CHILLS 528 0.0045
642 BACTERIAL INFECTION 84 0.0045
643 DYSGEUSIA 334 0.0045
644 OROPHARYNGEAL PAIN 416 0.0045
645 LIMB DISCOMFORT 139 0.0045
646 HYPOCALCAEMIA 85 0.0045
647 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 46 0.0045
648 SECRETION DISCHARGE 56 0.0045
649 SQUAMOUS CELL CARCINOMA 42 0.0045
650 ASPARTATE AMINOTRANSFERASE INCREASED 237 0.0045
651 MYOSITIS 40 0.0045
652 CANDIDA INFECTION 75 0.0044
653 LUNG INFECTION 69 0.0044
654 MOBILITY DECREASED 319 0.0044
655 RED BLOOD CELL SEDIMENTATION RATE INCREASED 49 0.0044
656 NASAL CONGESTION 260 0.0044
657 ARTHRALGIA 1835 0.0044
658 LYMPHOCYTE COUNT DECREASED 78 0.0044
659 RESPIRATORY DISORDER 132 0.0044
660 ANGIOEDEMA 195 0.0044
661 EAR INFECTION 117 0.0044
662 FEELING ABNORMAL 1052 0.0044
663 SEPTIC SHOCK 191 0.0044
664 WEIGHT INCREASED 982 0.0044
665 MUSCULOSKELETAL STIFFNESS 384 0.0044
666 INJECTION SITE EXTRAVASATION 54 0.0044
667 SPEECH DISORDER 229 0.0044
668 MYELODYSPLASTIC SYNDROME 63 0.0044
669 ABDOMINAL DISTENSION 454 0.0043
670 SWELLING 407 0.0043
671 LIGAMENT SPRAIN 43 0.0043
672 PULMONARY ARTERIAL HYPERTENSION 63 0.0043
673 TOOTH EXTRACTION 54 0.0043
674 CONVULSION 247 0.0043
675 TRANSAMINASES INCREASED 96 0.0043
676 THERAPY INTERRUPTED 308 0.0043
677 TOOTHACHE 78 0.0043
678 THROMBOCYTOPENIA 481 0.0043
679 THINKING ABNORMAL 80 0.0043
680 PULMONARY EMBOLISM 407 0.0043
681 SOMNOLENCE 861 0.0043
682 KNEE OPERATION 42 0.0043
683 METASTASES TO LIVER 75 0.0043
684 SURGERY 250 0.0043
685 HAIR COLOUR CHANGES 53 0.0043
686 BLISTER 239 0.0043
687 ELECTROCARDIOGRAM QT PROLONGED 153 0.0042
688 ASCITES 125 0.0042
689 PAIN 2612 0.0042
690 HAEMORRHAGE 444 0.0042
691 HYPOAESTHESIA ORAL 64 0.0042
692 NASOPHARYNGITIS 781 0.0042
693 LIP SWELLING 141 0.0042
694 PRODUCT DOSE OMISSION ISSUE 1245 0.0042
695 RASH MACULAR 148 0.0042
696 IMPAIRED WORK ABILITY 90 0.0042
697 ERECTILE DYSFUNCTION 108 0.0042
698 FEELING JITTERY 80 0.0042
699 DIPLOPIA 109 0.0042
700 NO THERAPEUTIC RESPONSE 51 0.0042
701 HEAD DISCOMFORT 74 0.0042
702 MALAISE 1833 0.0042
703 NEOPLASM 48 0.0042
704 CEREBRAL INFARCTION 102 0.0042
705 EYE IRRITATION 240 0.0042
706 BLOOD GLUCOSE ABNORMAL 77 0.0042
707 PRURITUS 1600 0.0042
708 METASTASES TO LUNG 48 0.0042
709 RENAL PAIN 44 0.0041
710 DRUG DOSE OMISSION 686 0.0041
711 BRAIN FOG 65 0.0041
712 METASTASES TO BONE 68 0.0041
713 LUNG DISORDER 203 0.0041
714 NIGHTMARE 143 0.0041
715 GENERAL PHYSICAL HEALTH DETERIORATION 476 0.0041
716 HEREDITARY ANGIOEDEMA 44 0.0041
717 RESTLESSNESS 150 0.0041
718 IMMUNE SYSTEM DISORDER 54 0.0041
719 OCULAR DISCOMFORT 46 0.0041
720 ILLNESS 422 0.0041
721 VISUAL ACUITY REDUCED 136 0.0041
722 ARTHROPATHY 227 0.0041
723 VOMITING 1920 0.0041
724 IMPAIRED HEALING 134 0.0041
725 HEPATIC FAILURE 123 0.0041
726 CYANOSIS 64 0.0041
727 INTENTIONAL DOSE OMISSION 116 0.0041
728 PRODUCT USE COMPLAINT 64 0.0041
729 ABDOMINAL PAIN 945 0.0041
730 NODULE 53 0.0041
731 DEAFNESS 106 0.0040
732 EYE DISCHARGE 42 0.0040
733 PSORIATIC ARTHROPATHY 164 0.0040
734 HEADACHE 2527 0.0040
735 DRY EYE 201 0.0040
736 VIRAL INFECTION 134 0.0040
737 MOTOR DYSFUNCTION 41 0.0040
738 ABSCESS 64 0.0040
739 INTESTINAL OBSTRUCTION 151 0.0040
740 PARANOIA 69 0.0040
741 POISONING 50 0.0040
742 PALLOR 108 0.0040
743 INFECTION 571 0.0039
744 MYOCLONUS 47 0.0039
745 JOINT SWELLING 474 0.0039
746 SENSORY DISTURBANCE 63 0.0039
747 EYE SWELLING 146 0.0039
748 FUNGAL INFECTION 130 0.0039
749 CARDIOVASCULAR DISORDER 99 0.0039
750 LYMPHADENOPATHY 138 0.0039
751 CONTRAINDICATED PRODUCT ADMINISTERED 118 0.0039
752 DRUG INTOLERANCE 376 0.0039
753 ALANINE AMINOTRANSFERASE INCREASED 238 0.0039
754 RASH 1688 0.0039
755 PANIC ATTACK 141 0.0039
756 RASH GENERALISED 100 0.0039
757 DRUG DISPENSING ERROR 59 0.0039
758 HIP ARTHROPLASTY 59 0.0038
759 ACUTE RESPIRATORY DISTRESS SYNDROME 68 0.0038
760 CHOKING 75 0.0038
761 PROTEINURIA 73 0.0038
762 CYTOPENIA 47 0.0038
763 WRONG TECHNIQUE IN DRUG USAGE PROCESS 139 0.0038
764 TENDON RUPTURE 47 0.0038
765 GASTROINTESTINAL DISORDER 341 0.0038
766 THIRST 68 0.0038
767 THERAPY NON-RESPONDER 171 0.0038
768 EYE DISORDER 125 0.0038
769 VISUAL IMPAIRMENT 470 0.0038
770 INJECTION SITE HAEMATOMA 55 0.0038
771 PHOTOPHOBIA 71 0.0038
772 DISCOMFORT 230 0.0038
773 BONE DENSITY DECREASED 118 0.0038
774 SKIN INFECTION 42 0.0037
775 LACRIMATION INCREASED 113 0.0037
776 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 87 0.0037
777 APHONIA 52 0.0037
778 INTENTIONAL PRODUCT MISUSE 326 0.0037
779 BLOOD LACTATE DEHYDROGENASE INCREASED 59 0.0037
780 THERAPEUTIC PRODUCT EFFECT DECREASED 166 0.0037
781 SNEEZING 83 0.0037
782 PHOTOSENSITIVITY REACTION 61 0.0037
783 COVID-19 647 0.0037
784 NEOPLASM PROGRESSION 128 0.0037
785 MENTAL IMPAIRMENT 89 0.0037
786 SYNOVITIS 66 0.0037
787 GAIT INABILITY 122 0.0036
788 EMOTIONAL DISORDER 112 0.0036
789 PHARYNGITIS 45 0.0036
790 COGNITIVE DISORDER 168 0.0036
791 COMA 171 0.0036
792 DEATH 3093 0.0036
793 DEVICE RELATED INFECTION 55 0.0036
794 MENTAL DISORDER 155 0.0036
795 OCULAR HYPERAEMIA 169 0.0036
796 FEEDING DISORDER 72 0.0035
797 CONDITION AGGRAVATED 1075 0.0035
798 PARAESTHESIA ORAL 51 0.0035
799 DISEASE PROGRESSION 418 0.0035
800 SWELLING FACE 230 0.0035
801 MUSCULOSKELETAL DISORDER 67 0.0035
802 IMPAIRED DRIVING ABILITY 40 0.0035
803 MUSCLE TWITCHING 81 0.0035
804 PYREXIA 1211 0.0035
805 IRRITABLE BOWEL SYNDROME 75 0.0035
806 COLON CANCER 52 0.0035
807 SKIN FISSURES 68 0.0035
808 GAMMA-GLUTAMYLTRANSFERASE INCREASED 77 0.0035
809 MOUTH ULCERATION 73 0.0035
810 ALOPECIA 679 0.0035
811 INCREASED APPETITE 66 0.0035
812 PNEUMONITIS 94 0.0034
813 MADAROSIS 40 0.0034
814 BRAIN OEDEMA 43 0.0034
815 INFLUENZA LIKE ILLNESS 280 0.0034
816 ASTHMA 381 0.0034
817 MALIGNANT MELANOMA 45 0.0034
818 PRODUCT DISPENSING ERROR 73 0.0033
819 DERMATITIS ALLERGIC 42 0.0033
820 THERAPEUTIC RESPONSE UNEXPECTED 149 0.0033
821 BLINDNESS 135 0.0033
822 JAUNDICE 89 0.0033
823 TOXICITY TO VARIOUS AGENTS 557 0.0033
824 BRONCHOSPASM 47 0.0033
825 ERYTHEMA 677 0.0033
826 MEDICATION ERROR 182 0.0033
827 INTENTIONAL PRODUCT USE ISSUE 286 0.0033
828 EMOTIONAL DISTRESS 394 0.0033
829 AGITATION 238 0.0032
830 DISABILITY 64 0.0032
831 FRACTURE 61 0.0032
832 FREQUENT BOWEL MOVEMENTS 86 0.0032
833 GLOSSODYNIA 71 0.0032
834 COLITIS 120 0.0032
835 MULTIPLE FRACTURES 52 0.0032
836 ABDOMINAL PAIN LOWER 80 0.0032
837 LOCAL SWELLING 55 0.0031
838 SKIN EXFOLIATION 265 0.0031
839 PRODUCT USE ISSUE 589 0.0031
840 PSORIASIS 408 0.0031
841 DISTURBANCE IN ATTENTION 167 0.0031
842 DRY SKIN 411 0.0031
843 DYSKINESIA 125 0.0031
844 LUNG NEOPLASM MALIGNANT 126 0.0031
845 ADVERSE DRUG REACTION 274 0.0030
846 DEPRESSED MOOD 161 0.0030
847 LYMPHOMA 47 0.0030
848 LIVER FUNCTION TEST INCREASED 65 0.0030
849 STEVENS-JOHNSON SYNDROME 67 0.0030
850 RASH ERYTHEMATOUS 144 0.0030
851 PERITONITIS 62 0.0030
852 PRODUCT SUBSTITUTION ISSUE 171 0.0030
853 HALLUCINATION, AUDITORY 47 0.0030
854 RHEUMATOID ARTHRITIS 334 0.0029
855 MULTIPLE SCLEROSIS 140 0.0029
856 THROAT TIGHTNESS 79 0.0029
857 DRUG PRESCRIBING ERROR 56 0.0029
858 OSTEONECROSIS OF JAW 72 0.0029
859 DRUG EFFECT LESS THAN EXPECTED 43 0.0029
860 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 206 0.0029
861 PHARMACEUTICAL PRODUCT COMPLAINT 75 0.0029
862 ACUTE MYELOID LEUKAEMIA 45 0.0029
863 PRODUCT QUALITY ISSUE 390 0.0029
864 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 204 0.0029
865 HYPERSENSITIVITY 530 0.0029
866 FEBRILE NEUTROPENIA 189 0.0028
867 NEOPLASM MALIGNANT 190 0.0028
868 TENDONITIS 44 0.0028
869 DISSEMINATED INTRAVASCULAR COAGULATION 40 0.0028
870 SEDATION 74 0.0028
871 NEUTROPHIL COUNT DECREASED 115 0.0028
872 ROAD TRAFFIC ACCIDENT 118 0.0028
873 IMMUNODEFICIENCY 42 0.0028
874 DIABETIC KETOACIDOSIS 67 0.0028
875 NERVOUS SYSTEM DISORDER 87 0.0028
876 URTICARIA 463 0.0028
877 LEUKOPENIA 138 0.0028
878 FEMUR FRACTURE 85 0.0027
879 APATHY 40 0.0027
880 INJECTION SITE MASS 101 0.0027
881 RASH PAPULAR 61 0.0027
882 OFF LABEL USE 2378 0.0027
883 INTENTIONAL OVERDOSE 174 0.0027
884 HEPATOTOXICITY 60 0.0027
885 MIGRAINE 257 0.0027
886 SUICIDE ATTEMPT 163 0.0027
887 PRODUCT AVAILABILITY ISSUE 61 0.0027
888 DRUG EFFECT DECREASED 144 0.0027
889 DRUG EFFECT INCOMPLETE 97 0.0027
890 C-REACTIVE PROTEIN INCREASED 97 0.0027
891 ADVERSE EVENT 241 0.0026
892 PSYCHOMOTOR HYPERACTIVITY 43 0.0026
893 EYE PRURITUS 87 0.0026
894 MALIGNANT NEOPLASM PROGRESSION 263 0.0026
895 IRRITABILITY 154 0.0026
896 NEUTROPENIA 345 0.0025
897 MOOD ALTERED 69 0.0025
898 ABNORMAL BEHAVIOUR 100 0.0025
899 ILL-DEFINED DISORDER 153 0.0025
900 PERICARDITIS 42 0.0025
901 SEROTONIN SYNDROME 48 0.0025
902 SEIZURE 284 0.0025
903 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 442 0.0025
904 CRYING 89 0.0024
905 DERMATITIS 51 0.0024
906 INTERSTITIAL LUNG DISEASE 117 0.0024
907 MOOD SWINGS 77 0.0024
908 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 131 0.0024
909 HEPATITIS 61 0.0024
910 RASH MACULO-PAPULAR 53 0.0024
911 CONJUNCTIVITIS 44 0.0024
912 ANGER 80 0.0024
913 INFLAMMATION 122 0.0024
914 PRODUCT USE IN UNAPPROVED INDICATION 583 0.0023
915 CHOLESTASIS 45 0.0023
916 PROCEDURAL PAIN 65 0.0023
917 NEUROTOXICITY 41 0.0023
918 MULTIPLE ORGAN DYSFUNCTION SYNDROME 66 0.0023
919 PREMATURE BABY 70 0.0023
920 PRESCRIBED OVERDOSE 45 0.0023
921 MULTIPLE SCLEROSIS RELAPSE 157 0.0023
922 INCORRECT DOSE ADMINISTERED 522 0.0023
923 PANCREATIC CARCINOMA 66 0.0023
924 INFUSION RELATED REACTION 151 0.0023
925 TARDIVE DYSKINESIA 64 0.0023
926 DRUG INEFFECTIVE 2989 0.0023
927 TOOTH LOSS 47 0.0023
928 DRUG ADMINISTRATION ERROR 69 0.0022
929 CYTOKINE RELEASE SYNDROME 45 0.0022
930 ACCIDENTAL OVERDOSE 82 0.0022
931 ECZEMA 117 0.0022
932 PSYCHOTIC DISORDER 66 0.0022
933 PAIN OF SKIN 60 0.0022
934 HEPATIC FUNCTION ABNORMAL 83 0.0022
935 DISEASE RECURRENCE 105 0.0022
936 NEEDLE ISSUE 64 0.0022
937 THERAPEUTIC RESPONSE DECREASED 133 0.0022
938 DEVICE MALFUNCTION 154 0.0022
939 SUICIDAL IDEATION 198 0.0022
940 PRESCRIBED UNDERDOSE 43 0.0022
941 PRODUCT ADMINISTRATION ERROR 43 0.0021
942 PRODUCT PRESCRIBING ISSUE 46 0.0021
943 LIVER INJURY 51 0.0021
944 MUCOSAL INFLAMMATION 54 0.0021
945 INJECTION SITE PRURITUS 137 0.0020
946 ALTERED STATE OF CONSCIOUSNESS 44 0.0020
947 PRODUCT PRESCRIBING ERROR 48 0.0020
948 AGGRESSION 99 0.0020
949 DRUG-INDUCED LIVER INJURY 61 0.0019
950 SKIN BURNING SENSATION 137 0.0019
951 EXTRAPYRAMIDAL DISORDER 47 0.0019
952 SYSTEMIC LUPUS ERYTHEMATOSUS 66 0.0019
953 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 62 0.0018
954 OVERDOSE 388 0.0018
955 WITHDRAWAL SYNDROME 75 0.0018
956 INJECTION SITE BRUISING 142 0.0018
957 UNDERDOSE 129 0.0018
958 INJECTION SITE HAEMORRHAGE 141 0.0018
959 VAGINAL HAEMORRHAGE 76 0.0017
960 INCORRECT DRUG ADMINISTRATION DURATION 49 0.0017
961 INJECTION SITE ERYTHEMA 212 0.0017
962 DERMATITIS ATOPIC 90 0.0017
963 OSTEONECROSIS 55 0.0017
964 ANAPHYLACTIC REACTION 92 0.0017
965 SKIN IRRITATION 74 0.0016
966 INJECTION SITE REACTION 110 0.0016
967 TREATMENT FAILURE 130 0.0016
968 BREAST CANCER FEMALE 41 0.0015
969 INJECTION SITE RASH 47 0.0015
970 DRUG EXPOSURE DURING PREGNANCY 52 0.0015
971 INJECTION SITE PAIN 468 0.0015
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 304 0.0015
973 INJECTION SITE SWELLING 108 0.0014
974 EXTRA DOSE ADMINISTERED 56 0.0014
975 EXPIRED PRODUCT ADMINISTERED 45 0.0014
976 LOWER RESPIRATORY TRACT INFECTION 60 0.0013
977 EPILEPSY 40 0.0013
978 DEVICE ISSUE 117 0.0013
979 PROSTATE CANCER 96 0.0012
980 COLITIS ULCERATIVE 53 0.0012
981 MATERNAL EXPOSURE DURING PREGNANCY 102 0.0011
982 DRUG WITHDRAWAL SYNDROME 95 0.0011
983 ACNE 79 0.0010
984 NO ADVERSE EVENT 186 0.0010
985 FOETAL EXPOSURE DURING PREGNANCY 82 0.0010
986 DEVICE LEAKAGE 43 0.0010
987 BLADDER CANCER 55 0.0009
988 BREAST CANCER 87 0.0009
989 DEVICE DISLOCATION 40 0.0009
990 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 42 0.0009
991 DRUG ABUSE 67 0.0008
992 PRODUCT STORAGE ERROR 49 0.0006
993 ACCIDENTAL EXPOSURE TO PRODUCT 57 0.0006
994 DRUG DEPENDENCE 80 0.0005